Navigation Links
From Autism to Diabetes to Parkinson's Disease: Pew Funds 22 Early-Career Scientists to Take Calculated Risks
Date:6/13/2013

PHILADELPHIA, June 13, 2013 /PRNewswire-USNewswire/ -- Twenty-two of the nation's most enterprising researchers were named Pew Scholars in the Biomedical Sciences by The Pew Charitable Trusts today. The scholarships provide flexible funding to early-career scientists researching the basis of perplexing health problems such as diabetes, autism, Parkinson's disease, and cancer. The new scholars join a prestigious community of researchers who have gone on to become Nobel laureates, MacArthur fellows, Albert Lasker Basic Medical Research Award winners, and hundreds of other pioneers who earned Pew grants at the start of their careers.

"The Pew scholars program gives innovative scientists both the freedom to take calculated risks and the resources to pursue the most promising, but untried, avenues for scientific breakthroughs," said Rebecca W. Rimel, president and CEO of Pew. "Pew funding provides an 'insurance policy,' allowing our scientists to be adventurous with their research. Though their scientific fields are diverse, their commitment is uniform: harnessing scientific discovery to improve human health."

The scholars program, launched in 1985, has granted more than $120 million in funding to more than 500 scientists at the beginning of their independent careers. The rigorously competitive program awards recipients $240,000 over four years to pursue their projects without direction or restriction. To be considered, applicants must demonstrate excellence and creativity in their research. This year, 179 institutions were invited to nominate a candidate, and 134 eligible nominations were received.

"Now more than ever, young scientists need the support to pursue untested leads," said Craig C. Mello, Ph.D., a 1995 Pew scholar and a 2006 Nobel laureate in physiology or medicine. "I am confident that these gifted scholars will make tremendous contributions to science. Their work will provide the world with new knowledge and tools to do tomorrow what seems impossible today."

Pew also directs the Pew Latin American Fellows Program in the Biomedical Sciences, which for 22 years has provided support to young Latin American scientists receiving postdoctoral training in the United States.

The 2013 Pew biomedical scholars are:

Hillel Adesnik, Ph.D.
University of California, Berkeley
Neuroscience

Mark Andermann, Ph.D.
Beth Israel Deaconess Medical Center
Neuroscience

Bo Chen, Ph.D.
Yale University School of Medicine
Neuroscience

Claudio Giraudo, Ph.D.
The Children's Hospital of Philadelphia
Cell biology and immunology

Andrew Goodman, Ph.D.
Yale University
Microbiology

Viviana Gradinaru, Ph.D.
California Institute of Technology
Neuroscience

Sergei Grivennikov, Ph.D.
Fox Chase Cancer Center
Cancer biology and immunology

Andrew Huberman, Ph.D.
University of California, San Diego
Developmental neurobiology

Suckjoon Jun, Ph.D.
University of California, San Diego
Quantitative and physical biology

Shingo Kajimura, Ph.D.
University of California, San Francisco
Developmental biology and metabolism

Jeffrey Kidd, Ph.D.
University of Michigan Medical School
Genomics

April Kloxin, Ph.D.
University of Delaware
Bioengineering and integrative biology

Fei Li, Ph.D.
New York University
Gene regulation and chromatin biology

Shelly Peyton, Ph.D.
University of Massachusetts, Amherst
Bioengineering and cancer biology

Manu Prakash, Ph.D.
Stanford University School of Medicine
Bioengineering and insect ecology

Avital Rodal, Ph.D.
Brandeis University
Neuroscience

June Round, Ph.D.
University of Utah
Microbiology and immunology

Alexander Sobolevsky, Ph.D.
Columbia University Medical Center
Biochemistry and molecular biophysics

Leo Wan, Ph.D.
Rensselaer Polytechnic Institute
Bioengineering

Ilana Witten, Ph.D.
Princeton University
Neuroscience

Qi Wu, Ph.D.
University of Iowa
Neuroscience and energy metabolism

Qiaobing Xu, Ph.D.
Tufts University
Bioengineering

For information regarding the scholars' research, please visit http://directory.pewscholars.org/

The Pew Charitable Trusts (www.pewtrusts.org) is driven by the power of knowledge to solve today's most challenging problems. Pew applies a rigorous, analytical approach to improve public policy, inform the public, and stimulate civic life. We partner with a diverse range of donors, public and private organizations, and concerned citizens who share our commitment to fact-based solutions and goal-driven investments to improve society.

Related Links:
Pew Scholars Program in the Biomedical Sciences


'/>"/>
SOURCE The Pew Charitable Trusts
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Curemark LLC Announces Positive Pre-NDA Meeting With FDA for New Drug Application for CM-AT for Autism
2. Same Problems in "New" Research on Autism and Vaccines
3. New Autism Detection System Commercialized through Partnership of IP Shakti, LLC and Shizuoka University
4. OptiNose Receives Grant to Fund Nose-to-Brain Research in Autism Spectrum Disorders
5. OptiNose mottar stipend for nese-til-hjerne-forskning innen spektrumet for autismesykdommer
6. Health Partner Sauna & Generation Rescue Partner to Bring Awareness of Infrared Sauna Benefits to Autism
7. Nectid Announces Initiation Of Clinical Development Of Autism And Pain Drugs
8. Phreesia identifies over 26% of patients who require additional autism evaluation
9. Metabolic Solutions Development Company announces publication of data describing potential for new drugs to maintain pancreatic beta-cells in treating diabetes
10. Health Diagnostic Laboratory, Inc. Announces Diabetes Prevention & Management Panel for Early Detection and Treatment of Disease
11. GlucoMen Launch App to Help Improve Diabetes Control
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... BRISBANE, Australia , Feb. 23, 2017  Directors from Pharma ... the two companies have joined forces, resulting in the founding of ... . Pharma To Market are pleased to announce their ... an office in Singapore . The company are ... Consulting as Co-Director of the Singapore based ...
(Date:2/24/2017)... 2017 Non-alcoholic steatohepataitis (NASH) Pipeline ... drugs being developed for the treatment of ... that are in various phases of development ... on novel pharmacologic drugs & regenerative medicines ... recombinant proteins and RNA-based therapeutics, but excludes ...
(Date:2/24/2017)... , Feb 24, 2017 Medivir ... proposal for a new Board of Directors that will ... 2016-2017 Nomination Committee comprises representatives of the company,s three ... of 2016 who have accepted a seat on the ... composition of the 2016-2017 Nomination Committee was as follows:  ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... February 24, 2017 , ... Yisrayl Hawkins, Pastor and ... Bible Prophecy concerning this present generation. Yisrayl makes an astounding statement when he ... He explains that the Bible details the current times so plainly that anyone ...
(Date:2/24/2017)... ... ... The Radiology Business Management Association will select the 2017 Quest ... Better Radiology Marketing Programs conference, held this year from March 5 to 7 ... given out in five categories. They are:, ,     Patient Marketing, a ...
(Date:2/24/2017)... ... February 24, 2017 , ... Castle Farms, the celebrated ... Giveaway, with the winning couple announced on Feb. 14, 2017, on Facebook. The ... local vendors: A Matter of Taste, Ryan Rousseau Enterprises, A Touch of Spring ...
(Date:2/23/2017)... ... 23, 2017 , ... The 89th Academy Awards will be celebrated this weekend, ... Policy Center Bunkum Award. We invite you to enjoy our 11th annual tongue-in-cheek “salute” ... is the Center for American Progress (CAP), for its report, Lessons From State Performance ...
(Date:2/23/2017)... Chapel Hill, NC (PRWEB) , ... February 23, 2017 , ... ... the Platinum Sponsor for ACPA’s 74th Annual Meeting. KLS is a longtime supporter ... in 2017 as an exhibitor and Platinum Sponsor," said Dr. Bob Havlik, 2017 ACPA ...
Breaking Medicine News(10 mins):